Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Details Narrative)

v3.22.1
Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]      
Cash cash equivalents and restricted cash   $ 250 $ 250
Marketable securities, unrealized loss $ 484 $ 92  
Net accumulated unrealized losses $ 629   $ 145